Interferon Beta 1a in Hospitalized COVID-19 Patients

NCT04350671 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Interferon Beta-1A
DRUG: Lopinavir / Ritonavir
DRUG: Single Dose of Hydroxychloroquine

Sponsor

Shahid Beheshti University of Medical Sciences